Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Del Nagro

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritisChristopher J Del Nagro, Ravi V Kolla, Robert C Rickert
Immunity|November 10, 2009
Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergyCecille D Browne, Christopher J Del Nagro, Matthew H Cato, et al.
Plos One|November 23, 2013
Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeysCheng-Ping Mao, Martin R Brovarney, Karim Dabbagh, et al.
Immunologic Research|March 22, 2005
CD19 function in central and peripheral B-cell developmentChristopher J Del Nagro, Dennis C Otero, Amy N Anzelon, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2013
Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell deathChristopher J Del Nagro, Jonathan Choi, Yang Xiao, et al.
Analytical Chemistry|May 28, 2020
Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody-Drug ConjugateYue Huang, Christopher J Del Nagro, Kemal Balic, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritisChristopher J Del Nagro, Ravi V Kolla, Robert C Rickert
Immunity|November 10, 2009
Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergyCecille D Browne, Christopher J Del Nagro, Matthew H Cato, et al.
Plos One|November 23, 2013
Subcutaneous versus intravenous administration of rituximab: pharmacokinetics, CD20 target coverage and B-cell depletion in cynomolgus monkeysCheng-Ping Mao, Martin R Brovarney, Karim Dabbagh, et al.
Immunologic Research|March 22, 2005
CD19 function in central and peripheral B-cell developmentChristopher J Del Nagro, Dennis C Otero, Amy N Anzelon, et al.
Cell Cycle (Georgetown, Tex.)|November 20, 2013
Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell deathChristopher J Del Nagro, Jonathan Choi, Yang Xiao, et al.
Analytical Chemistry|May 28, 2020
Multifaceted Bioanalytical Methods for the Comprehensive Pharmacokinetic and Catabolic Assessment of MEDI3726, an Anti-Prostate-Specific Membrane Antigen Pyrrolobenzodiazepine Antibody-Drug ConjugateYue Huang, Christopher J Del Nagro, Kemal Balic, et al.
Pageof 1